We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
Cap. Flow
+$2.23B
Cap. Flow %
1.36%
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157

Top Buys

Rank Stock Value
1
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$520M
2
UNH icon
UnitedHealth
UNH
+$332M
3
ADI icon
Analog Devices
ADI
+$320M
4
FIS icon
Fidelity National Information Services
FIS
+$265M
5
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$237M

Top Sells

Rank Stock Value
1
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$516M
2
SMMV icon
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
+$512M
3
CSCO icon
Cisco
CSCO
+$348M
4
AAPL icon
Apple
AAPL
+$162M
5
DVN icon
Devon Energy
DVN
+$142M

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Financials 8.92%
3 Healthcare 7.98%
4 Industrials 6.57%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DURA icon
3326
VanEck Durable High Dividend ETF
DURA
$39.1M
$347K ﹤0.01%
9,977
-31
-0.3% -$1.03K
RGNX icon
3327
Regenxbio
RGNX
$616M
$344K ﹤0.01%
32,809
-4,416
-12% -$53.8K
VAL icon
3328
Valaris
VAL
$5.14B
$344K ﹤0.01%
6,169
-894
-13% -$58.6K
VBF icon
3329
Invesco Bond Fund
VBF
$167M
$343K ﹤0.01%
20,164
+122
+0.6% +$2.02K
M icon
3330
Macy's
M
$6.51B
$343K ﹤0.01%
21,833
-358
-2% -$5.81K
PROF
3331
Profound Medical
PROF
$263M
$342K ﹤0.01%
43,005
+4,090
+11% +$37K
PTCT icon
3332
PTC Therapeutics
PTCT
$6.18B
$342K ﹤0.01%
+9,219
New +$309K
HDMV icon
3333
First Trust Horizon Managed Volatility Developed International ETF
HDMV
$17.5M
$341K ﹤0.01%
10,832
-36,350
-77% -$1.1M
CCJ icon
3334
CALL
Cameco
CCJ
$36.8B
$340K ﹤0.01%
9,700
– –
RFG icon
3335
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$330M
$338K ﹤0.01%
6,881
+392
+6% +$18.9K
XPH icon
3336
State Street SPDR S&P Pharmaceuticals ETF
XPH
$481M
$337K ﹤0.01%
7,602
+373
+5% +$16K
XTN icon
3337
State Street SPDR S&P Transportation ETF
XTN
$390M
$337K ﹤0.01%
4,083
-11,002
-73% -$860K
PIO icon
3338
Invesco Global Water ETF
PIO
$271M
$336K ﹤0.01%
7,809
+494
+7% +$20.4K
EWW icon
3339
iShares MSCI Mexico ETF
EWW
$1.89B
$335K ﹤0.01%
6,245
+725
+13% +$40.3K
AMR icon
3340
Alpha Metallurgical Resources
AMR
$1.77B
$335K ﹤0.01%
1,420
-4,566
-76% -$1.17M
MSD
3341
Morgan Stanley Emerging Markets Debt Fund
MSD
$146M
$334K ﹤0.01%
42,169
– –
MVT
3342
DELISTED
BlackRock MuniVest Fund II
MVT
$334K ﹤0.01%
29,318
-4,440
-13% -$49.7K
HHH icon
3343
Howard Hughes
HHH
$3.94B
$332K ﹤0.01%
4,291
-9,564
-69% -$675K
AVSC icon
3344
Avantis US Small Cap Equity ETF
AVSC
$3.04B
$332K ﹤0.01%
+6,148
New +$324K
FLNG icon
3345
FLEX LNG
FLNG
$1.69B
$331K ﹤0.01%
13,023
-4,640
-26% -$123K
BBIO icon
3346
BridgeBio Pharma
BBIO
$16.4B
$331K ﹤0.01%
13,004
+2,188
+20% +$57.4K
OEC icon
3347
Orion
OEC
$403M
$331K ﹤0.01%
+18,562
New +$358K
SZNE
3348
DELISTED
Pacer CFRA-Stoval Equal Weight Seasonal Rotation ETF
SZNE
$330K ﹤0.01%
8,439
-1,933
-19% -$73.6K
QINT icon
3349
American Century Quality Diversified International ETF
QINT
$654M
$330K ﹤0.01%
6,378
+176
+3% +$8.77K
CX icon
3350
Cemex
CX
$16.9B
$329K ﹤0.01%
53,923
-123,055
-70% -$772K
132 133
134
135 136

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
  • Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
  • Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
  • Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
  • Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
  • Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
  • Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.